Tempest Therapeutics Inc.

TPST | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.82

+$0.05 (+5.97%)

Sep 22, 2026, 12:30 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	7.71M	30.27M	39.23M	31.23M	51.83M	18.82M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	388K	n/a	n/a	n/a	n/a
Other Long-Term Assets	517K	97K	448K	429K	111K	51K
Receivables	n/a	n/a	n/a	450K	15M	260K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	355K	535K	96K	263K	553K	59K
Total Current Assets	8.27M	31.47M	40.36M	32.95M	68.96M	19.83M
Property-Plant & Equipment	8.15M	9.53M	10.79M	12.71M	4.16M	2.99M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.66M	10.01M	11.24M	13.14M	4.28M	3.04M
Total Assets	16.93M	41.49M	51.6M	46.09M	73.24M	22.86M
Account Payables	1.04M	2.45M	845K	1.11M	991K	1.07M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	6.35M	4.29M	n/a	n/a	n/a
Other Current Liabilities	147K	1.76M	1.79M	1.25M	912K	774K
Total Current Liabilities	3.31M	14.22M	9.41M	7.28M	20.03M	3.22M
Long-Term Debt	6.95M	n/a	6.26M	10.37M	15.07M	n/a
Other Long-Term Liabilities	n/a	0	n/a	n/a	n/a	86.71M
Total Long-Term Liabilities	6.95M	8.14M	15.42M	20.7M	17.1M	88.43M
Total Liabilities	10.26M	22.36M	24.84M	27.98M	37.12M	91.66M
Total Debt	8.14M	15.37M	20.66M	22.11M	18.54M	2.44M
Book Value	6.67M	19.13M	26.77M	18.11M	36.12M	-68.79M
Book Value Per Share	1.61	0.69	1.74	20.39	123.87	-2.2K
Common Stock	5K	44K	22K	11K	7K	1K
Retained Earnings	-233.37M	-207.11M	-165.26M	-135.77M	-100.06M	-71.76M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	6.67M	19.13M	26.77M	18.11M	36.12M	-68.79M
Total Investments	n/a	388K	n/a	n/a	n/a	n/a